Gabriella Guarnieri

Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance

L. De Franceschi, M. Caminati, R. Benoni, 2023, Orphanet Journal of Rare Diseases.

Time-series analysis of multidimensional clinical-laboratory data by dynamic Bayesian networks reveals trajectories of COVID-19 outcomes

A. Avogaro, B. Camillo, G. Fadini, 2022, Computer Methods and Programs in Biomedicine.

The Safety of a High-Flow Nasal Cannula in Neuromuscular Disease Patients with Acute Respiratory Failure: A Retrospective Case-Series Study

G. Arcaro, A. Padoan, B. Molena, 2023, Journal of clinical medicine.

Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study.

F. Cinetto, L. Losappio, R. Solans, 2023, The Lancet. Rheumatology.

Asthma management, focused on the use of oral corticosteroids: the opinions of Italian asthmatic patients.

M. Caminati, E. Ridolo, G. Scioscia, 2024, The Journal of asthma : official journal of the Association for the Care of Asthma.

Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)

F. Granata, M. Caminati, E. Ridolo, 2024, Cells.

Time-series analysis of multidimensional clinical-laboratory data by dynamic Bayesian networks reveals trajectories of COVID-19 outcomes

B. Camillo, G. Fadini, M. Morieri, 2022, Computer Methods and Programs in Biomedicine.